BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7093949)

  • 1. Trapping of DNA-reactive metabolites of therapeutic or carcinogenic agents by carbon-14-labeled synthetic polynucleotides.
    Mehta JR; Ludlum DB
    Cancer Res; 1982 Aug; 42(8):2996-9. PubMed ID: 7093949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of metabolites of cyclophosphamide to DNA in a rat liver microsomal system and in vivo in mice.
    Hemminki K
    Cancer Res; 1985 Sep; 45(9):4237-43. PubMed ID: 4028012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione conjugation with phosphoramide mustard and cyclophosphamide. A mechanistic study using tandem mass spectrometry.
    Yuan ZM; Smith PB; Brundrett RB; Colvin M; Fenselau C
    Drug Metab Dispos; 1991; 19(3):625-9. PubMed ID: 1680629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for peroxidase-mediated metabolism of cyclophosphamide.
    Kanekal S; Kehrer JP
    Drug Metab Dispos; 1993; 21(1):37-42. PubMed ID: 8095224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of cyclophosphamide with DNA in isolated rat liver cell nuclei.
    Lindemann H
    Anticancer Res; 1984; 4(1-2):53-8. PubMed ID: 6712177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid detection and characterization of reactive drug metabolites in vitro using several isotope-labeled trapping agents and ultra-performance liquid chromatography/time-of-flight mass spectrometry.
    Rousu T; Pelkonen O; Tolonen A
    Rapid Commun Mass Spectrom; 2009 Mar; 23(6):843-55. PubMed ID: 19224530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of reactive metabolites in drug-induced teratogenesis.
    Hales BF; Slott VL
    Prog Clin Biol Res; 1987; 253():181-91. PubMed ID: 3432286
    [No Abstract]   [Full Text] [Related]  

  • 9. Formation of a phosphoramide mustard-nucleotide adduct that is not by alkylation at the N7 position of guanine.
    Maccubbin AE; Caballes L; Chheda GB; Struck RF; Gurtoo HL
    Biochem Biophys Res Commun; 1989 Sep; 163(2):843-50. PubMed ID: 2783126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative disposition of phosphoramide mustard and other cyclophosphamide metabolites in the mouse using the Salmonella/mutagenesis assay.
    Suling WJ; Struck RF; Woolley CW; Shannon WM
    Cancer Treat Rep; 1978 Sep; 62(9):1321-8. PubMed ID: 356985
    [No Abstract]   [Full Text] [Related]  

  • 11. Nature of the binding of activated cyclophosphamide to calf thymus DNA and pBR-322 plasmid DNA.
    Bansal SK; Love JH; Faletto MB; Gurtoo HL; Struck RF
    Cancer Biochem Biophys; 1986 Jul; 8(3):193-202. PubMed ID: 3742481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclophosphamide metabolism in children.
    Yule SM; Boddy AV; Cole M; Price L; Wyllie R; Tasso MJ; Pearson AD; Idle JR
    Cancer Res; 1995 Feb; 55(4):803-9. PubMed ID: 7850793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro biotransformation and genotoxicity of the drinking water disinfection byproduct bromodichloromethane: DNA binding mediated by glutathione transferase theta 1-1.
    Ross MK; Pegram RA
    Toxicol Appl Pharmacol; 2004 Mar; 195(2):166-81. PubMed ID: 14998683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of the cytochrome P450 mechanism-based inhibitor N-benzyl-1-aminobenzotriazole to products that covalently bind with protein in guinea pig liver and lung microsomes: comparative study with 1-aminobenzotriazole.
    Woodcroft KJ; Webb CD; Yao M; Weedon AC; Bend JR
    Chem Res Toxicol; 1997 May; 10(5):589-99. PubMed ID: 9168258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative high-throughput trapping assay as a measurement of potential for bioactivation.
    Meneses-Lorente G; Sakatis MZ; Schulz-Utermoehl T; De Nardi C; Watt AP
    Anal Biochem; 2006 Apr; 351(2):266-72. PubMed ID: 16473319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP Technical Report on the metabolism, toxicity and predicted carcinogenicity of diazoaminobenzene (CAS No. 136-35-6).
    Ress NB;
    Toxic Rep Ser; 2002 Sep; (73):1-23, A1-C6. PubMed ID: 12370695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation in the metabolism of coumarin in mouse liver.
    Lovell DP; van Iersel M; Walters DG; Price RJ; Lake BG
    Pharmacogenetics; 1999 Apr; 9(2):239-50. PubMed ID: 10376771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunosuppressant effect of cyclophosphamide activated in vitro by liver microsomes from different strains of mice].
    Telegin LIu; Zhirnov GF; Mazurov AV; PevnitskiÄ­ LA
    Biull Eksp Biol Med; 1981 Jul; 92(7):57-60. PubMed ID: 7295946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of human glutathione S-transferase isoenzymes in the conjugation of cyclophosphamide metabolites with glutathione.
    Dirven HA; van Ommen B; van Bladeren PJ
    Cancer Res; 1994 Dec; 54(23):6215-20. PubMed ID: 7954469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of cyclophosphamide biotransformation in vivo.
    Domeyer BE; Sladek NE
    Cancer Res; 1980 Jan; 40(1):174-80. PubMed ID: 7349895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.